Patient Square Capital LP Diversified Active

Location: Menlo Park, CA

CIK: 0001819257 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 14, 2025

Total Value: $242M (100.0% shares, 0.0% debt)

Holdings (19)

ROIV ROIVANT SCIENCES LTD. 52.1%

Value $126M Shares 12,480,000 Est. Cost $7.21 Unrealized +49.9%

INSM INSMED INC 10.4%

Value $25.19M Shares 330,250 Est. Cost $73.26 Unrealized +4.4%

LQDA LIQUIDIA CORPORATION 9.3%

Value $22.46M Shares 1,522,452 Est. Cost $13.90 Unrealized +4.9%

EYPT EYEPOINT PHARMACEUTICALS, INC. 3.3%

Value $8.032M Shares 1,481,977 Est. Cost $8.71 Unrealized -19.7%

OCUL OCULAR THERAPEUTIX, INC. 2.8%

Value $6.745M Shares 920,199 Est. Cost $8.36 Unrealized -8.0%

CGEM CULLINAN THERAPEUTICS, INC. 2.8%

Value $6.653M Shares 878,897 Est. Cost $17.53 Unrealized -45.3%

NRIX NURIX THERAPEUTICS, INC. 2.2%

Value $5.314M Shares 447,296 Est. Cost $22.73 Unrealized -26.4%

MIRM MIRUM PHARMACEUTICALS, INC. 2.2%

Value $5.242M Shares 116,362 Est. Cost $44.09 Unrealized +6.9%

ELVN ENLIVEN THERAPEUTICS, INC. 2.1%

Value $4.996M Shares 253,838 Est. Cost $24.42 Unrealized -11.9%

SRRK SCHOLAR ROCK HOLDING CORPORATION 2.0%

Value $4.951M Shares 154,000 Est. Cost $37.24 Unrealized +3.3%

IRON DISC MEDICINE, INC. 1.7%

Value $4.12M Shares 83,000 Est. Cost $57.12 Unrealized -2.7%

AGIO AGIOS PHARMACEUTICALS, INC. 1.7%

Value $4.094M Shares 139,732 Est. Cost $45.20 Unrealized -26.6%

KYMR KYMERA THERAPEUTICS, INC. 1.6%

Value $3.892M Shares 142,201 Est. Cost $36.45 Unrealized 0.0%

PHVS PHARVARIS N. V. 1.6%

Value $3.854M Shares 245,496 Est. Cost $18.06 Unrealized -6.6%

ALLO ALLOGENE THERAPEUTICS, INC. 1.4%

Value $3.458M Shares 2,368,186 Est. Cost $2.25 Unrealized -16.2%

— BLUEPRINT MEDICINES CORPORATION 1.4%

Value $3.408M Shares 38,500 Est. Cost $88.51 Unrealized —

NTLA INTELLIA THERAPEUTICS, INC. 0.7%

Value $1.655M Shares 232,781 Est. Cost $19.32 Unrealized -47.7%

SLNO SOLENO THERAPEUTICS, INC. 0.5%

Value $1.329M Shares 18,600 Est. Cost $48.69 Unrealized 0.0%

VYNE VYNE THERAPEUTICS INC. 0.2%

Value $406K Shares 257,033 Est. Cost $2.46 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ROIV	ROIVANT SCIENCES LTD.	12,480,000	$126M	52.1%	$7.21	+49.9%	SHS	G76279101
INSM	INSMED INC	330,250	$25.19M	10.4%	$73.26	+4.4%	COM PAR $.01	457669307
LQDA	LIQUIDIA CORPORATION	1,522,452	$22.46M	9.3%	$13.90	+4.9%	COM NEW	53635D202
EYPT	EYEPOINT PHARMACEUTICALS, INC.	1,481,977	$8.032M	3.3%	$8.71	-19.7%	COM NEW	30233G209
OCUL	OCULAR THERAPEUTIX, INC.	920,199	$6.745M	2.8%	$8.36	-8.0%	COM	67576A100
CGEM	CULLINAN THERAPEUTICS, INC.	878,897	$6.653M	2.8%	$17.53	-45.3%	COM	230031106
NRIX	NURIX THERAPEUTICS, INC.	447,296	$5.314M	2.2%	$22.73	-26.4%	COM	67080M103
MIRM	MIRUM PHARMACEUTICALS, INC.	116,362	$5.242M	2.2%	$44.09	+6.9%	COM	604749101
ELVN	ENLIVEN THERAPEUTICS, INC.	253,838	$4.996M	2.1%	$24.42	-11.9%	COM	29337E102
SRRK	SCHOLAR ROCK HOLDING CORPORATION	154,000	$4.951M	2.0%	$37.24	+3.3%	COM	80706P103
IRON	DISC MEDICINE, INC.	83,000	$4.12M	1.7%	$57.12	-2.7%	COM	254604101
AGIO	AGIOS PHARMACEUTICALS, INC.	139,732	$4.094M	1.7%	$45.20	-26.6%	COM	00847X104
KYMR	KYMERA THERAPEUTICS, INC.	142,201	$3.892M	1.6%	$36.45	0.0%	COM	501575104
PHVS	PHARVARIS N. V.	245,496	$3.854M	1.6%	$18.06	-6.6%	COM	N69605108
ALLO	ALLOGENE THERAPEUTICS, INC.	2,368,186	$3.458M	1.4%	$2.25	-16.2%	COM	019770106
—	BLUEPRINT MEDICINES CORPORATION	38,500	$3.408M	1.4%	$88.51	—	COM	09627Y109
NTLA	INTELLIA THERAPEUTICS, INC.	232,781	$1.655M	0.7%	$19.32	-47.7%	COM	45826J105
SLNO	SOLENO THERAPEUTICS, INC.	18,600	$1.329M	0.5%	$48.69	0.0%	COM	834203309
VYNE	VYNE THERAPEUTICS INC.	257,033	$406K	0.2%	$2.46	0.0%	COM	92941V308